市場調查報告書

全球乳糖不耐症治療市場:至2025年的預測

Global Lactose Intolerance Treatment Market Research Report Forecast to 2025

出版商 Market Research Future 商品編碼 918810
出版日期 內容資訊 英文 124 Pages
訂單完成後即時交付
價格
全球乳糖不耐症治療市場:至2025年的預測 Global Lactose Intolerance Treatment Market Research Report Forecast to 2025
出版日期: 2019年11月30日內容資訊: 英文 124 Pages
簡介

全球乳糖不耐症治療市場至2025年預計將以以7.1%成長,2025年達到410億5,440萬美元的規模。腸胃障礙的劇增,乳糖不耐症治療和相關障礙的認識高漲,乳糖不耐症治療的發生率增加等,為該市場的成長要素。

本報告提供全球乳糖不耐症治療市場的相關調查,市場機會,成長及阻礙因素,各類型、療法、形狀、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 市場介紹

  • 簡介
  • 前提條件、限制
    • 前提條件
    • 限制事項
  • 市場結構

第3章 調查方法

  • 調查方法
  • 資料探勘
  • 二次調查
  • 一次調查
  • 預測手法
  • 市場規模估計的調查方法
    • Bottom-Up(由下而上)方法
    • Top-Down(由上而下)方法
    • 資料三角測量
    • 檢驗

第4章 市場動態

  • 簡介
  • 成長要素
    • 腸胃障礙的案例增加
    • 乳糖不耐症及相關的併發症相關意識的高漲
    • 乳糖不耐症的盛行率增加
  • 阻礙因素
    • 補充品相關的副作用
  • 市場機會

第5章 市場要素分析

  • 價值鏈分析
    • 研究開發
    • 製造業
    • 流通、銷售
    • 銷售後的監測
  • 波特的五力分析
    • 新加入廠商的威脅
    • 供應商談判力
    • 替代品的威脅
    • 買主談判力
    • 產業內的競爭
  • 投資機會

第6章 市場分析:各類型

  • 簡介
  • 一次乳糖不耐症
  • 二次乳糖不耐症
  • 先天性/發展性乳糖不耐症

第7章 市場分析:各療法

  • 簡介
  • 營養補充品
  • 酵素乳糖酵素補充品
  • 益生菌

第8章 市場分析:各形狀

  • 簡介
  • 粉末
  • 液體
  • 錠劑、膠囊

第9章 市場分析:各終端用戶

  • 簡介
  • 居家護理
  • 醫院、診療所

第10章 市場分析:各地區

  • 簡介
  • 南北美洲
    • 北美
    • 南美
  • 歐洲
    • 西歐
    • 東歐
  • 亞太地區
    • 中國
    • 澳洲
    • 日本
    • 印度
    • 韓國
    • 其他
  • 中東、非洲
    • 中東
    • 非洲

第11章 競爭情形

  • 簡介
  • 企業佔有率分析

第12章 企業簡介

  • Johnson & Johnson Services, Inc.
  • Nestle
  • Abbott
  • Deerland Enzymes, Inc.
  • Ritter Pharmaceuticals
  • Guardian Drug Company
  • Novozymes
  • Cargill, Incorporated
  • Arla Foods
  • Dean Foods

第13章 附錄

  • 參照資料
  • 相關報告
目錄

Global lactose intolerance treatment market: Information by Type of Lactose Intolerance Treatment (Primary, Secondary, Congenital/Developmental Lactose Intolerance), by Form (Tablets/Capsules, Enzyme Lactase Supplement, Probiotics), by Treatment (Food Supplements, Enzyme Lactase Supplements, Probiotics), by Form (Powder, Liquid, Tablets & Capsules), by End User (Homecare, Hospitals & Clinics) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market analysis

Generally, Lactose Intolerance treatment is a medical situation identified by lactase (lactose digesting enzyme) deficiency within the patient's body. As a result, lactose lingers unharmed and unabsorbed producing various ill-consequences such as flatulence, inflating, intestinal pains, and others. There are four types of lactose prejudice, namely, primary lactase deficiency, secondary lactase deficiency, frequent lactase deficiency, and liberal lactase deficiency. The Global Lactose Intolerance Treatment Market is anticipated to reach a CAGR of 7.10% and reach USD 41,054.4 Million by 2025. Lactose Intolerance treatment is a digestive problem with an impaired ability to digest lactose. Factors such as soaring cases of gastrointestinal disorders, increasing awareness about Lactose Intolerance treatment and related impediments, and enhanced occurrence of Lactose Intolerance treatment are the driving forces for the market. However, side-effects combined with supplements is projected to restraint the market during the forecast period (2019-2025). Secondary lactase insufficiency mainly occurs due to irritable bowel syndrome (IBS), gastroenteritis, Crohn disease, ulcerative colitis, celiac disease, chemotherapy, and antibiotics. In April-2017, Abbott introduced science-based nutrition drinks to help patients have a better recovery from surgery. New Ensure Surgery Immunonutrition Shake and Ensure Pre-Surgery Clear Nutrition Drink is designed for hospitals implementing surgical guidelines for enhancing patient recovery. These drinks are also lactose-free. As per the study suggested by the Journal of Health, Population, and Nutrition in 2017, the prevalence of Lactose Intolerance treatment was significantly higher in IBS-D patients than in healthy individuals. In this study, some eligible IBS-D patients and healthy individuals were enrolled.

Market segmentation

The global Lactose Intolerance treatment market has been segmented by type of lactose intolerance, treatment, form, and end user. In March-2018, Nestle completed its acquisition of Atrium Innovations Inc., a global chief in nutritious health goods. This acquisition supports Nestle's hunt of growth occasions in consumer healthcare to complement the company's focus on its high-growth food and beverage classes The market, based on type, has been bifurcated into primary lactose intolerance, secondary lactose intolerance, and hereditary/evolving lactose intolerance. In May,2016- Dean Foods launched a new DairyPure brand, lactose free milk to its line of dairy products. DairyPure lactose-free milk delivers real dairy nutrition and delectable taste. Also, it is 100% lactose-free, making it easy to digest for those with lactose understandings. Based on form, the Lactose Intolerance treatment market has been separated into food supplements, enzyme lactase supplements, probiotics, and others (combination products and prebiotics). By form, the global Lactose Intolerance treatment market has been divided into tablets/capsule, powder, and liquid. Based on end-user, the market has been apportioned into home care and hospitals & clinics.

Regional analysis

Geographically the Global Lactose Intolerance Treatment Market is split in regions like North & South America, Europe, Asia-Pacific, Middle east and Africa and Rest of the world. Consumers in this region are looking for more accessible ways to shop. They seek to acquire products from a single location or store, and it is one of the main handlers of hypermarkets and hypermarkets in Latin America. Asia-Pacific is the third-leading region and held the market share of 20.0% in 2018. In terms of value, it has the largest dairy consumption, but it has the lowest per capita income spent on dairy foods as it is still cultivating better foundation for the distribution of chilled dairy products. The Middle East and Africa is highly obsolescence with per capita splurge on dairy at just USD 25 per head, the lowest in the world. Also, Europe held the main market share of 42.0% in 2018. The dairy consumption in Western Europe is good in comparison to other regions of Europe and has a high per-capita utilization rate during the region. The Americas conducted the second major market share of 28% in 2018. It is more segmented into North and Latin America. The expenditure of dairy goods is also noticeable and changeable in the Americas. Latin America, for example, is one of the fastest-growing dairy markets in the world.

Major players

The proposed spectators in the Global Lactose Intolerance Treatment Market are Detonator manufacturers, Retailers, distributors, wholesalers, Investors and trade experts, Governments, associations, industrial bodies, etc. The major companies functioning in the Global Lactose Intolerance Treatment Market are concentrating on firming their global ways by entering into untouched markets. The projected onlookers in the Global Lactose Intolerance Treatment Market are companies like Cargill, Incorporated (US), Abbott Laboratories, Inc. (US), Dean Foods (US), Johnson & Johnson, Inc. (US), Novozyme, (Denmark) and Nestle (Switzerland).

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Introduction
  • 2.2 Assumptions & Limitations
    • 2.2.1 Assumptions
    • 2.2.2 Limitations
  • 2.3 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Data Mining
  • 3.3 Secondary Research
  • 3.4 Primary Research
  • 3.5 Forecasting Techniques
  • 3.6 Research Methodology for Market Size Estimation
    • 3.6.1 Bottom-Up Approach
    • 3.6.2 Top-Down Approach
    • 3.6.3 Data Triangulation
    • 3.6.4 Validation

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Rising Cases of Gastrointestinal Disorders
    • 4.2.2 Increasing Awareness About Lactose Intolerance and Related Complications
    • 4.2.3 Increased Prevalence of Lactose Intolerance
  • 4.3 Restraints
    • 4.3.1 Side-Effects Associated with Supplements
  • 4.4 Opportunities

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-Sales Monitoring
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Threat of New Entrants
    • 5.2.2 Bargaining Power of Suppliers
    • 5.2.3 Threat of Substitutes
    • 5.2.4 Bargaining Power of Buyers
    • 5.2.5 Intense Rivalry
  • 5.3 Investment Opportunities

6 Global Lactose Intolerance Treatment Market, by Type

  • 6.1 Introduction
  • 6.2 Primary Lactose Intolerance
  • 6.3 Secondary Lactose Intolerance
  • 6.4 Congenital/Developmental Lactose Intolerance

7 Global Lactose Intolerance Treatment Market, by Treatment

  • 7.1 Introduction
  • 7.2 Food Supplements
  • 7.3 Enzyme Lactase Supplements
  • 7.4 Probiotics

8 Global Lactose Intolerance Treatment Market, by Form

  • 8.1 Introduction
  • 8.2 Powder
  • 8.3 Liquid
  • 8.4 Tablets & Capsules

9 Global Lactose Intolerance Treatment Market by, End User

  • 9.1 Introduction
  • 9.2 Homecare
  • 9.3 Hospitals & Clinics

10 Global Lactose Intolerance Treatment Market, by Region

  • 10.1 Introduction
  • 10.2 Americas
    • 10.2.1 North America
      • 10.2.1.1 US
      • 10.2.1.2 Canada
    • 10.2.2 Latin America
  • 10.3 Europe
    • 10.3.1 Western Europe
      • 10.3.1.1 Germany
      • 10.3.1.2 France
      • 10.3.1.3 UK
      • 10.3.1.4 Italy
      • 10.3.1.5 Spain
      • 10.3.1.6 Rest of Western Europe
    • 10.3.2 Eastern Europe
  • 10.4 Asia-Pacific
    • 10.4.1 China
    • 10.4.2 Australia
    • 10.4.3 Japan
    • 10.4.4 India
    • 10.4.5 South Korea
    • 10.4.6 Rest of the Asia-Pacific
  • 10.5 Middle East & Africa
    • 10.5.1 Middle East
    • 10.5.2 Africa

11 Competitive Landscape

  • 11.1 Introduction
  • 11.2 Company Share Analysis

12 Company Profiles

  • 12.1 Johnson & Johnson Services, Inc.
    • 12.1.1 Company Overview
    • 12.1.2 Financial Overview
    • 12.1.3 Products/Services Offered
    • 12.1.4 Key Developments
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Strategies
  • 12.2 Nestle
    • 12.2.1 Company Overview
    • 12.2.2 Financial Overview
    • 12.2.3 Products/Services Offered
    • 12.2.4 Key Developments
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Strategies
  • 12.3 Abbott
    • 12.3.1 Company Overview
    • 12.3.2 Financial Overview
    • 12.3.3 Products/Services Offered
    • 12.3.4 Key Developments
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Strategies
  • 12.4 Deerland Enzymes, Inc.
    • 12.4.1 Company Overview
    • 12.4.2 Financial Overview
    • 12.4.3 Products/Services Offered
    • 12.4.4 Key Developments
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Strategies
  • 12.5 Ritter Pharmaceuticals
    • 12.5.1 Company Overview
    • 12.5.2 Financial Overview
    • 12.5.3 Products/Services Offered
    • 12.5.4 Key Developments
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Strategies
  • 12.6 Guardian Drug Company
    • 12.6.1 Company Overview
    • 12.6.2 Financial Overview
    • 12.6.3 Products/Services Offered
    • 12.6.4 Key Developments
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Strategies
  • 12.7 Novozymes
    • 12.7.1 Company Overview
    • 12.7.2 Financial Overview
    • 12.7.3 Products/Services Offered
    • 12.7.4 Key Developments
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Strategies
  • 12.8 Cargill, Incorporated
    • 12.8.1 Company Overview
    • 12.8.2 Financial Overview
    • 12.8.3 Products/Services Offered
    • 12.8.4 Key Developments
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Strategies
  • 12.9 Arla Foods
    • 12.9.1 Company Overview
    • 12.9.2 Financial Overview
    • 12.9.3 Products/Services Offered
    • 12.9.4 Key Developments
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Strategies
  • 12.1 Dean Foods
    • 12.10.1 Company Overview
    • 12.10.2 Financial Overview
    • 12.10.3 Products/Services Offered
    • 12.10.4 Key Developments
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Strategies

13 Appendix

  • 13.1 References
  • 13.2 Related Reports

List of Tables

  • TABLE 1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 3 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PRIMARY LACTOSE INTOLERANCE, BY REGION 2018 & 2025 (USD MILLION)
  • TABLE 4 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR SECONDARY LACTOSE INTOLERANCE, BY REGION 2018 & 2025 (USD MILLION)
  • TABLE 5 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE, BY REGION 2018 & 2025 (USD MILLION)
  • TABLE 6 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 7 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR FOOD SUPPLEMENT, BY REGION 2018 & 2025 (USD MILLION)
  • TABLE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR ENZYME LACTASE SUPPLEMENTS, BY REGION 2018 & 2025 (USD MILLION)
  • TABLE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR PROBIOTICS, BY REGION 2018 & 2025 (USD MILLION)
  • TABLE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR POWDER, BY REGION 2016-2025 (USD MILLION)
  • TABLE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR LIQUID, BY REGION 2016-2025 (USD MILLION)
  • TABLE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR TABLETS/CAPSULES, BY REGION 2016-2025 (USD MILLION)
  • TABLE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOME CARE, BY REGION 2016-2025 (USD MILLION)
  • TABLE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET FOR HOSPITAL & CLINICS, BY REGION 2016-2025 (USD MILLION)
  • TABLE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2016-2025 (USD MILLION)
  • TABLE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2016-2025 (USD MILLION)
  • TABLE 19 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 20 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 21 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 22 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 23 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2016-2025 (USD MILLION)
  • TABLE 24 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 25 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 26 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 27 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 28 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 29 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 30 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 31 US: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 32 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 33 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 34 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 35 CANADA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 36 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 37 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 38 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 39 LATIN AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 40 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2016-2025 (USD MILLION)
  • TABLE 41 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 42 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 43 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 44 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 45 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2016-2025 (USD MILLION)
  • TABLE 46 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 47 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 48 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 49 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 50 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 51 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 52 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 53 GERMANY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 54 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 55 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 56 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 57 FRANCE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 58 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 59 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 60 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 61 UK: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 62 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 63 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 64 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 65 ITALY: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 66 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 67 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 68 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 69 SPAIN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 70 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 71 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 72 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 73 REST OF WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 74 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 75 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 76 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 77 EASTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2016-2025 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 83 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 84 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 85 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 86 CHINA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 87 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 88 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 89 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 90 AUSTRALIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 91 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 92 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 93 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 94 JAPAN: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 95 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 96 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 97 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 98 INDIA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 99 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 100 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 101 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 102 SOUTH KOREA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 103 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 104 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 105 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 106 REST OF THE ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 107 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2016-2025 (USD MILLION)
  • TABLE 108 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 109 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 110 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 111 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 112 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 113 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 114 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 115 MIDDLE EAST: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • TABLE 116 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2016-2025 (USD MILLION)
  • TABLE 117 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2016-2025 (USD MILLION)
  • TABLE 118 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • TABLE 119 AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET: MARKET STRUCTURE
  • FIGURE 3 PRIMARY RESPONDENT'S BREAKDOWN
  • FIGURE 4 BOTTOM-UP AND TOP-DOWN APPROACH
  • FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET
  • FIGURE 6 VALUE CHAIN: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET
  • FIGURE 7 PORTER'S FIVE FORCES ANALYSIS: GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET
  • FIGURE 8 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2018 (%)
  • FIGURE 9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE 2018 & 2025 (USD MILLION)
  • FIGURE 10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2018 (%)
  • FIGURE 11 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT 2018 & 2025 (USD MILLION)
  • FIGURE 12 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2018 (%)
  • FIGURE 13 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM 2016-2025 (USD MILLION)
  • FIGURE 14 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2018 (%)
  • FIGURE 15 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY END USER 2016-2025 (USD MILLION)
  • FIGURE 16 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION2016-2025 (USD MILLION)
  • FIGURE 17 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2018 (%)
  • FIGURE 18 AMERICAS: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2018 (%)
  • FIGURE 19 NORTH AMERICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2018 (%)
  • FIGURE 20 EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2018 (%)
  • FIGURE 21 WESTERN EUROPE: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2018 (%)
  • FIGURE 22 ASIA-PACIFIC: LACTOSE INTOLERANCE TREATMENT MARKET, BY COUNTRY 2018 (%)
  • FIGURE 23 MIDDLE EAST & AFRICA: LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION 2018 (%)
  • FIGURE 24 GLOBAL LACTOSE INTOLERANCE TREATMENT MAJOR PLAYERS MARKET SHARE ANALYSIS, 2018 (%)